The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and Mounjaro, has announced a strategic ...
The Food and Drug Administration said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...
Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate blog, which has associated social media channels on YouTube, Facebook and Twitter.
Inside the dangerous world of Russian front-line soldiers working as double agents for the enemy ...
"I’ve done 60 Minutes many times, even back in the good ol’ days when Journalism was respected and legit, but I have never seen a very poor answer being REPLACED by another, totally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback